How GLP-1 Receptor Agonists Work for Weight Management Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for type 2 diabetes management but increasingly recognised for their significant weight management properties
Protasiewicz-Timofticiuc DC, Badescu D, Mota M, et al
Some patients notice appetite suppression semaglutide week 1, but many do not feel significant restriction until the dose increases
The analysis included 10,997 adults with CM initiating a GLP-1 RA (liraglutide, semaglutide, dulaglutide, exenatide, lixisenatide, or albiglutide) within 12 months of diagnosis, as well as matched adults initiating topiramate
Trusted by 50,000+ GLP-1 users No spam, ever Why Sleep Is Critical for Weight Loss on GLP-1s Getting adequate, restful sleep isn't just about feeling good the next day it's a critical component of your metabolic health journey